S100B and schizophrenia: Therefore, an increased adipose tissue mass or changes of insulin metabolism such as insulin resistance most probably play a major role in increased S100B levels in schizophrenia too, given the increased prevalence of obesity and metabolic syndrome in patients and their first-degree relatives (see above) [55, 56].